# Skin & Aesthetics Peptide FAQ — GHK-Cu, GLOW, Melanotan II — Peptide Renewal Serum

> Frequently asked questions about three Skin & Aesthetics research peptides — GHK-Cu, GLOW, and Melanotan II — answered from the peer-reviewed literature, with citations.

Direct, citation-anchored answers to the questions readers most often bring to these three Skin & Aesthetics research peptides.

## What does a GHK-Cu peptide do?

GHK-Cu is studied mainly for its effect on skin and connective tissue. In cell and human studies, it increases synthesis of collagen, elastin, and the glycosaminoglycans that give skin its structure, and it helps cross-link that new tissue into a stable matrix [1][4][7]. It is also studied for wound healing, where it increases growth factors and repair-cell recruitment while suppressing inflammatory signaling [6], and for hair growth, where a GHK-containing formula outperformed placebo in a six-month controlled trial [3]. Topical Copper Tripeptide-1 is a legal cosmetic ingredient; the peptide is not approved as an injectable or oral drug.

## What is GHK-Cu and how does it work?

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine — three amino acids bound to a copper atom. It occurs naturally in the body and declines with age [4]. It works by signaling skin fibroblasts, at very low concentrations, to produce more collagen and elastin, while its copper ion enables an enzyme (lysyl oxidase) to cross-link that new tissue into a stable structure [1][7]. Gene-expression studies also link it to broader shifts toward wound-repair, antioxidant, and DNA-repair gene activity [2].

## Is GHK-Cu peptide really anti-aging?

The evidence supports a specific, narrower claim than 'anti-aging' as a whole. Controlled and cell-based studies link topical GHK-Cu to increased collagen production — 70% of treated subjects showed increased procollagen synthesis versus 50% for vitamin C and 40% for retinoic acid in the studies reviewed — along with firmer, more elastic skin and reduced fine lines in placebo-controlled work [1][4]. That is a documented cosmetic effect on skin appearance, not a demonstrated effect on aging as a biological process. Much of the broader anti-aging literature is preclinical or extrapolated from gene-expression data, not confirmed in large human trials [2].

## What is the difference between GHK and GHK-Cu?

GHK is the plain tripeptide, glycyl-L-histidyl-L-lysine, with no metal attached. GHK-Cu is the same tripeptide bound to a copper(II) ion. The distinction matters: most of the documented tissue-remodeling activity in the research literature — collagen stimulation, matrix-enzyme rebalancing — depends on the copper being properly bound. Cell studies show the copper-free peptide does not reproduce key effects, such as stimulating certain matrix-remodeling enzymes, that the copper-bound form does. Products or preparations where the copper has come loose from the peptide may not behave as the cited research describes.

## What is GLOW peptide?

GLOW is not a single peptide — it is a combination product, typically three peptides sold together: GHK-Cu, BPC-157, and TB-500. Each has its own separate research literature; GLOW itself has not been tested as a combination in any controlled trial [8][9]. A commonly cited research-label ratio pairs the three, but ratios are supplier-specific and unstandardized, not a studied formula.

## What does the GLOW peptide do?

GLOW's rationale layers three separate mechanisms: GHK-Cu's collagen and matrix-building activity on skin [4], BPC-157's blood-vessel-growth and tissue-protective activity [10], and TB-500's role in cell migration during tissue repair. Research-use accounts describe brighter, smoother-looking skin and faster-looking wound and scar healing, but these are anecdotal, not clinical evidence — no study has measured the combined blend's actual effect on any outcome [8][9].

## What does GLOW peptide have in it?

The version of GLOW described in research and supplier literature contains three peptides: GHK-Cu (a copper-bound tripeptide, roughly 403 daltons), BPC-157 (a synthetic 15-amino-acid peptide, roughly 1,419 daltons), and TB-500 (an acetylated 7-amino-acid fragment of thymosin beta-4, roughly 889 daltons). A commonly cited research-label ratio is 10 milligrams BPC-157, 10 milligrams TB-500, and 50 milligrams GHK-Cu, though this is a supplier convention, not a studied or standardized formula.

## What peptides are in the GLOW blend?

Three: GHK-Cu, BPC-157, and TB-500. GHK-Cu is a copper-binding tripeptide studied for skin matrix and hair [1][4]. BPC-157 is a stable fragment of a gastric protective protein, studied for tissue repair and blood-vessel growth in animal models, with only three small human pilot studies published [9][10]. TB-500 is the synthetic actin-binding fragment of thymosin beta-4, a protein involved in cell migration and wound closure. None of the three has been studied in combination as GLOW.

## What is Melanotan 2?

Melanotan II is a lab-made, cyclic peptide designed in the late 1980s as a stronger, longer-lasting analog of alpha-melanocyte-stimulating hormone (alpha-MSH), the natural hormone that governs skin and hair pigmentation. It has never been approved as a medicine anywhere. It reached small controlled human trials for tanning and erectile dysfunction decades ago [15] and is now mainly documented through case reports of serious adverse effects in unsupervised users [11][13].

## What is Melanotan 2 used for in research?

In published research, Melanotan II has been studied for skin and hair pigmentation, appetite regulation, and erectile function. A controlled crossover trial in 10 men with psychogenic erectile dysfunction found it produced clinically apparent erections in the large majority of participants [15]. Animal studies show it selectively reduces food intake and food-motivated behavior through brain melanocortin receptors [12]. Recent case-report research also documents its adverse effects, including oral-mucosal pigmentation [11] and renal infarction [13] in people using it outside of any trial.

## How does Melanotan 2 work in the body?

Melanotan II is a non-selective agonist of the melanocortin receptors (MC1R through MC5R) — it activates all five rather than one. In skin cells, activating MC1R raises cAMP and switches on a signaling cascade that increases tyrosinase activity, driving pigment production without requiring UV exposure. In the brain, activating MC3R and MC4R in the hypothalamus mediates its appetite-suppressing and pro-sexual effects, documented in both animal [12] and early human [15] studies. Because it activates receptors across skin, brain, and other tissue at once, its effects rarely appear in isolation.

## What is the melanogenesis (MC1R-cAMP-MITF) signaling cascade?

This is the chain of signaling steps inside a skin pigment cell (melanocyte) that produces pigment. A hormone or peptide binds MC1R, a receptor on the cell surface. That binding raises a molecule called cAMP inside the cell, which activates an enzyme (PKA), which in turn activates a gene-regulating protein (CREB), which switches on a master pigment-production gene called MITF. MITF then increases tyrosinase, the enzyme that converts a precursor into eumelanin, the dark pigment. Melanotan II drives this entire cascade directly by activating MC1R, which is why it produces pigmentation without sun exposure.

---

A citation-anchored digest on renewal-serum peptides. Not a serum. Not a clinic. Not advice.